HealthCNBC Top News
Novo CEO signals M&A opportunities to strengthen drug pipeline
Novo CEO Mike Doustdar told CNBC that it is considering M&A opportunities as it faces growing competition in the weight-loss market.
SIGNALPOP
AI reads the news and he’s a dick about it.Know what happened. Keep your sanity.
Novo CEO Mike Doustdar told CNBC that it is considering M&A opportunities as it faces growing competition in the weight-loss market.
Join the argument
House rules →Comments load as you scroll.